BETTER/SMARTER.ME
Supporting Self-Enhancement Science for the Success of Society
Logo
The Institute for the Future of Human Potential
☰
VOLUME XIX | JUL 2018

Commentary: Metformin reverses TRAP1 mutation-associated alterations in mitochondrial function in Parkinson’s disease

Dr. David Lowemann
Dr. David Lowemann
Dr. David Lowemann, M.Sc, Ph.D., is a co-founder of the Institute for the Future of Human Potential, where he leads the charge in pioneering

Sachchida N. Rai, Saumitra S. Singh, Hareram Birla, Walia Zahra, Aaina S. Rathore, Payal Singh, Surya P. Singh

Read Full Article (External Site)

Related posts:

  1. Leucine Carboxyl Methyltransferase Downregulation and Protein Phosphatase Methylesterase Upregulation Contribute Toward the Inhibition of Protein Phosphatase 2A by α-Synuclein
  2. Commentary: Mild endoplasmic reticulum stress ameliorates lpopolysaccharide-induced neuroinflammation and cognitive impairment via regulation of microglial polarization
  3. Vitamin K Deficiency Induced by Warfarin Is Associated With Cognitive and Behavioral Perturbations, and Alterations in Brain Sphingolipids in Rats
  4. Evaluation of Metformin on Cognitive Improvement in Patients With Non-dementia Vascular Cognitive Impairment and Abnormal Glucose Metabolism